From: Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder
Age (y)
11.44 ± 1.51
Gender (% male)
67
Race (% white)
100
School grade
6.00 ± 1.77
ADD %
33
ADHD %
Years since diagnosis
2.63 ± 1.41
Height (in)
61.67 ± 5.13
Weight (lbs)
113.67 ± 34.04
Taking stimulant
medication (%)